Liu et al. suggest that BMMSCs have a tumor-promoting effect on head and neck cancer (HNC) through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin [36]. The gene discussed is MTOR; the disease is head and neck cancer.